迈得医疗
(688310)
| 流通市值：32.13亿 | | | 总市值：32.13亿 |
| 流通股本：1.66亿 | | | 总股本：1.66亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 224,643,650.85 | 141,000,652.85 | 40,176,271.66 | 274,850,777.34 |
| 营业收入 | 224,643,650.85 | 141,000,652.85 | 40,176,271.66 | 274,850,777.34 |
| 二、营业总成本 | 246,657,062.76 | 156,540,560.82 | 60,784,570.29 | 318,484,947.58 |
| 营业成本 | 134,362,178.2 | 86,111,225.43 | 26,963,318.79 | 154,321,842.42 |
| 税金及附加 | 5,130,573.09 | 3,623,805.82 | 1,605,798.89 | 6,079,081.77 |
| 销售费用 | 19,892,181.84 | 11,892,223.99 | 4,792,140.24 | 25,043,561.91 |
| 管理费用 | 56,682,363.02 | 37,755,216.77 | 18,622,624.24 | 95,212,930.99 |
| 研发费用 | 31,113,408.83 | 17,977,238.05 | 9,155,975.84 | 40,411,899.21 |
| 财务费用 | -523,642.22 | -819,149.24 | -355,287.71 | -2,584,368.72 |
| 其中:利息费用 | 1,119,302.28 | 652,400.18 | 245,935.81 | 64,132.37 |
| 其中:利息收入 | 1,118,713.5 | 718,745.49 | 174,748.26 | 3,091,924.37 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,358,333.06 | 1,270,153.83 | 608,227.12 | 3,064,357.51 |
| 加:投资收益 | 167,605.31 | 174,638.08 | -8,538.35 | -823,757.27 |
| 资产处置收益 | -59,989.15 | -39,911.63 | - | 440,196.02 |
| 资产减值损失(新) | -1,242,209.7 | -667,413.23 | -27,993.3 | -13,090,279.67 |
| 信用减值损失(新) | 566,691.31 | 938,013.27 | -713,060.15 | 3,726,813.69 |
| 其他收益 | 19,223,165.5 | 14,959,311.46 | 5,216,043.41 | 22,920,564.94 |
| 四、营业利润 | -999,815.58 | 1,094,883.81 | -15,533,619.9 | -27,396,275.02 |
| 加:营业外收入 | 2,382,865.17 | 2,382,861.2 | 2,247,860 | 321,003.18 |
| 减:营业外支出 | 631,838.29 | 298,911.17 | 204,579.17 | 2,156,565.63 |
| 五、利润总额 | 751,211.3 | 3,178,833.84 | -13,490,339.07 | -29,231,837.47 |
| 减:所得税费用 | 6,213,297.59 | 4,998,260.08 | -137,451.53 | 780,720.31 |
| 六、净利润 | -5,462,086.29 | -1,819,426.24 | -13,352,887.54 | -30,012,557.78 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -5,462,086.29 | -1,819,426.24 | -13,352,887.54 | -30,012,557.78 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 8,836,659.11 | 6,045,058.94 | -10,797,370.24 | -19,981,182.92 |
| 少数股东损益 | -14,298,745.4 | -7,864,485.17 | -2,555,517.3 | -10,031,374.86 |
| 扣除非经常损益后的净利润 | -1,278,531.67 | -2,514,883.74 | -14,391,563.09 | -26,280,944.9 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.05 | 0.04 | -0.07 | -0.12 |
| (二)稀释每股收益 | 0.05 | 0.04 | -0.07 | -0.12 |
| 八、其他综合收益 | -798,404.99 | -864,783.7 | -266,787.98 | 305,474.05 |
| 归属于母公司股东的其他综合收益 | -798,404.99 | -864,783.7 | -266,787.98 | 305,474.05 |
| 九、综合收益总额 | -6,260,491.28 | -2,684,209.94 | -13,619,675.52 | -29,707,083.73 |
| 归属于母公司股东的综合收益总额 | 8,038,254.12 | 5,180,275.24 | -11,064,158.22 | -19,675,708.87 |
| 归属于少数股东的综合收益总额 | -14,298,745.4 | -7,864,485.17 | -2,555,517.3 | -10,031,374.86 |
| 公告日期 | 2025-10-28 | 2025-08-28 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |